COVID-19 vaccine.Dr. Barbara Yaffe, Ontario’s associate chief medical officer of health, made the announcement during a news conference at Queen’s Park Tuesday afternoon.
She said a man in his 40s developed vaccine-induced immune thrombotic thrombocytopenia (VITT) after receiving his first dose of the vaccine at the end of April and died a few weeks later.
Ontario to provide 2nd dose of AstraZeneca COVID-19 vaccine after temporary suspension “While the investigation is ongoing and a final cause of death has yet to be officially determined, it has been confirmed the official did have VITT at the time of his death,” Yaffe told reporters.She said residents who had the AstraZeneca vaccine “should feel very confident” in their decision to get.